Show simple item record

dc.contributor.authorTran, Kim Tu
dc.contributor.authorMcMenamin, Úna C.
dc.contributor.authorHicks, Blánaid
dc.contributor.authorMurchie, Peter
dc.contributor.authorThrift, Aaron P.
dc.contributor.authorColeman, Helen G.
dc.contributor.authorIversen, Lisa
dc.contributor.authorJohnston, Brian T.
dc.contributor.authorLee, Amanda J.
dc.contributor.authorCardwell, Chris R.
dc.date.accessioned2019-05-08T23:02:11Z
dc.date.available2019-05-08T23:02:11Z
dc.date.issued2018-07
dc.identifier.citationTran , K T , McMenamin , Ú C , Hicks , B , Murchie , P , Thrift , A P , Coleman , H G , Iversen , L , Johnston , B T , Lee , A J & Cardwell , C R 2018 , ' Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies ' , Alimentary Pharmacology & Therapeutics , vol. 48 , no. 1 , pp. 55-64 . https://doi.org/10.1111/apt.14796en
dc.identifier.issn0269-2813
dc.identifier.otherPURE: 118877471
dc.identifier.otherPURE UUID: d68a80e6-f04f-45c0-9f4a-2332febe8e92
dc.identifier.otherScopus: 85047418442
dc.identifier.otherORCID: /0000-0001-9968-5991/work/83704281
dc.identifier.urihttp://hdl.handle.net/2164/12243
dc.descriptionThe analysis of UK Biobank has been conducted using the UK Biobank Resource under Application Number 34374. We acknowledge collaboration with the Research Applications and Data Management Team lead by Ms Katie Wilde, University of Aberdeen in conducting this study. KTT is supported by the Vietnam International Education Cooperation Department. Access to PCCIU data was provided by Queen’s University Belfast and the Centre for Academic Primary Care, University of Aberdeen. Access to the UK Biobank was funded by a Cancer Research UK Population Research Postdoctoral Fellowship awarded to ÚCMcM. HGC is a co-investigator of the UKCRC Centre of Excellence for Public Health Northern Ireland.en
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofAlimentary Pharmacology & Therapeuticsen
dc.rightsThis is the peer reviewed version of the following article: Tran KT, McMenamin ÚC, Hicks B, et al. Proton pump inhibitor and histamine‐2 receptor antagonist use and risk of liver cancer in two population‐based studies. Aliment Pharmacol Ther. 2018;48:55–64., which has been published in final form at https://doi.org/10.1111/apt.14796. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectCancer Research UKen
dc.subject.lccRC0254en
dc.titleProton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studiesen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Data Safe Havenen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Public Health, Health Services and Primary Careen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.contributor.institutionUniversity of Aberdeen.Medical Statisticsen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1111/apt.14796
dc.date.embargoedUntil2019-05-09


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record